Searchable abstracts of presentations at key conferences in obesity

ob0003ou1 | A year in review: what are the highlights? | OU2021

Developments in treatments for rare genetic obesities

Goldstone Tony

The area of genetic causes of syndromic and non-syndromic obesity has a large unmet clinical need to treat underlying hyperphagia. In recent years, improved understanding of underlying mechanisms resulting from the underlying gene(s) defects has revealed potential therapeutic targets, while designation of orphan disease has promoted the interest of biotechnology and pharmaceutical companies for these rare genetic obesities. This talk will review the emerging trial data on the ...